Target intelligence / Profile preview

Immune system – immunogen, not a pharmacological target

Molecular classification
Other
01

Overview

The classification "Immune system – immunogen, not a pharmacological target" is a specialized label used in pharmacological databases, such as ChEMBL (Target ID: CHEMBL2367078), to identify substances that function as antigens rather than traditional drug targets (Gaulton et al., 2017, Nucleic Acids Res). An immunogen is defined as any molecule, typically a protein or polysaccharide, capable of eliciting an adaptive immune response, including the production of specific antibodies or the activation of T-cells (CDC, 2023, "Glossary of Vaccinology Terms"). Unlike traditional pharmacological targets like receptors, enzymes, or transporters that are modulated by drugs to alter physiological signaling, immunogens are the active components of vaccines designed to induce long-term protective immunity (WHO, 2021, "How do vaccines work?"). This label is typically applied to viral proteins, bacterial toxins, or tumor-associated antigens when they are administered to stimulate the host's immune system to recognize and neutralize specific threats. Consequently, this entry does not represent a single biological entity but serves as a functional category for agents that facilitate active immunization (PubChem, 2024). The interaction between the immunogen and the immune system is the fundamental basis for prophylaxis against infectious diseases and certain types of therapeutic cancer vaccines.

Other names
ImmunogenAntigenVaccine antigenAntigenic stimulusActive immunity inducer
02

Mechanism of action

Induction of a specific immune response, involving both humoral (antibody) and cellular (T-cell) components, to provide active immunity and immunological memory against a specific pathogen or antigen.

03

Biological functions

Immune responseAdaptive immunityAntibody productionT-cell activation
04

Disease associations

InfectionCancerProphylaxis
05

Safety considerations

Injection site reactions (pain, swelling, redness)Hypersensitivity or anaphylaxisSystemic inflammatory response (fever, malaise)Potential for autoimmune cross-reactivity
06

Interacting drugs

Hepatitis B vaccine

4 more in the full profile.

07

Biomarkers

Antibody titer (IgG/IgM)Neutralizing antibody levelsAntigen-specific T-cell countCytokine release profile

Beyond the preview

Go deeper on Immune system – immunogen, not a pharmacological target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system – immunogen, not a pharmacological target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call